<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01950793</url>
  </required_header>
  <id_info>
    <org_study_id>2012-11-001A</org_study_id>
    <nct_id>NCT01950793</nct_id>
  </id_info>
  <brief_title>A Comparison Between Sonoguided Injection Corticosteroid and Hyaluronic Acid Injection in Treatment of Trigger Finger</brief_title>
  <official_title>Steroid Versus Hyaluronic Acid Ultrasound-guided Injection for Trigger Finger: A Comparative Study of Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Veterans General Hospital, Taiwan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is to compare the effect between steroid injection and Hyaluronic acid in treatment&#xD;
      trigger finger. Using sonoguided injection technique achieves more accurate injection&#xD;
      location and therapeutic effect. We hypothesize hyaluronic acid has both lubricant and&#xD;
      anti-inflammation effect in treatment of trigger finger, and can provide better outcome and&#xD;
      lower adverse effect than steroid injection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, double-blinded controlled study. Patients with the&#xD;
      diagnosis of trigger finger will be recruited and enrolled from Taipei Veteran General&#xD;
      Hospital PM&amp;R outpatient clinic. Subjects will be randomized into two groups; hyaluronic acid&#xD;
      and triamcinolone acetonide injections, both via ultrasound-guided with one injection only.We&#xD;
      hypothesize that through the anti-inflammatory property of the hyaluronate acid, the&#xD;
      treatment effects will be as effective as the traditionally used steroid injections with&#xD;
      equal or even lower recurrence rate for treatment of trigger finger. We expect that&#xD;
      injections of hyaluronate into tendon sheath could become a new treatment option for trigger&#xD;
      finger.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quinnell classification</measure>
    <time_frame>Pre-injection; 3-weeks and 3-months post-injections</time_frame>
    <description>he Quinnell system grades trigger fingers as:&#xD;
0 - normal movement&#xD;
- uneven movement&#xD;
- locking can be corrected with active motion&#xD;
- locking corrected with passive motion&#xD;
- unable to correct deformity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hand functional evaluation</measure>
    <time_frame>Pre-injection; 3-weeks and 3-months post-injections</time_frame>
    <description>using the Michigan Hand Outcome Questionnaire (MHQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analog scale</measure>
    <time_frame>Pre-injection; 3-weeks and 3-months post-injections</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total active motion (TAM)</measure>
    <time_frame>Pre-injection; 3-weeks and 3-months post-injections</time_frame>
    <description>Deﬁ ned as the total ROM achieved when all three joints-metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) of a digit are actively ﬂ exed or extended simultaneously, minus any extension deﬁ cit at any of the three joints</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>grip strength</measure>
    <time_frame>Pre-injection; 3-weeks and 3-months post-injections</time_frame>
    <description>dynamometer strength test (JAMAR grip)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Trigger Finger</condition>
  <arm_group>
    <arm_group_label>steroid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>used ultrasound-guided inject 1c.c triamcinolone acetonide 10mg/mL (Shincort®, YSP, Taiwan)into the sheath of the flexor tendons, penetrated to the A1 pulley.&#xD;
One injection only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyaluronic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>used ultrasound-guided inject 1c.c Hyaluronic acid (Artz®, Seikagaku, Japan)into the sheath of the flexor tendons, penetrated to the A1 pulley.&#xD;
One injection only</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>triamcinolone acetonide</intervention_name>
    <description>used ultrasound-guided inject 1c.c triamcinolone acetonide 10mg/mL (Shincort®, YSP, Taiwan)into the sheath of the flexor tendons, penetrated to the A1 pulley.&#xD;
One injection only Steroid</description>
    <arm_group_label>steroid</arm_group_label>
    <other_name>triamcinolone acetonide 10mg/mL (Shincort®, YSP, Taiwan)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyaluronic Acid</intervention_name>
    <description>used ultrasound-guided inject 1c.c Hyaluronic acid (Artz®, Seikagaku, Japan)into the sheath of the flexor tendons, penetrated to the A1 pulley.&#xD;
One injection only</description>
    <arm_group_label>Hyaluronic acid</arm_group_label>
    <other_name>Hyaluronic acid (Artz®, Seikagaku, Japan)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with trigger digits and patients&#xD;
&#xD;
          -  without previous treatment of the trigger digit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with prior treatment of the trigger digit (eg, splinting, injection, or&#xD;
             therapy),&#xD;
&#xD;
          -  patients less than&#xD;
&#xD;
          -  20 years old,&#xD;
&#xD;
          -  patients with allergy or contraindication to hyaluronic acid,&#xD;
&#xD;
          -  patients with trigger digits due to rheumatoid arthritis,&#xD;
&#xD;
          -  and patients with infection at the site of injection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chung-Lan Kao, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Taipei Veterans General Hospital, Taiwan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <study_first_submitted>September 23, 2013</study_first_submitted>
  <study_first_submitted_qc>September 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2013</study_first_posted>
  <last_update_submitted>November 2, 2014</last_update_submitted>
  <last_update_submitted_qc>November 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hyaluronic acid, trigger finger</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigger Finger Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

